ATE477803T1 - Metabolit von quetiapine - Google Patents
Metabolit von quetiapineInfo
- Publication number
- ATE477803T1 ATE477803T1 AT04743131T AT04743131T ATE477803T1 AT E477803 T1 ATE477803 T1 AT E477803T1 AT 04743131 T AT04743131 T AT 04743131T AT 04743131 T AT04743131 T AT 04743131T AT E477803 T1 ATE477803 T1 AT E477803T1
- Authority
- AT
- Austria
- Prior art keywords
- quetiapine
- metabolite
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/554—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having at least one nitrogen and one sulfur as ring hetero atoms, e.g. clothiapine, diltiazem
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48436503P | 2003-07-02 | 2003-07-02 | |
PCT/GB2004/002783 WO2005002586A1 (en) | 2003-07-02 | 2004-06-28 | Metabolite of quetiapine |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE477803T1 true ATE477803T1 (de) | 2010-09-15 |
Family
ID=33563981
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT04743131T ATE477803T1 (de) | 2003-07-02 | 2004-06-28 | Metabolit von quetiapine |
Country Status (20)
Country | Link |
---|---|
US (1) | US20050026900A1 (de) |
EP (1) | EP1644005B1 (de) |
JP (1) | JP2007516193A (de) |
KR (1) | KR20060082037A (de) |
CN (1) | CN1816339B (de) |
AR (1) | AR045004A1 (de) |
AT (1) | ATE477803T1 (de) |
AU (1) | AU2004253334A1 (de) |
BR (1) | BRPI0412127A (de) |
CA (1) | CA2531284A1 (de) |
DE (1) | DE602004028739D1 (de) |
ES (1) | ES2349091T3 (de) |
IL (1) | IL172616A0 (de) |
IS (1) | IS8283A (de) |
MX (1) | MXPA05013869A (de) |
NO (1) | NO20060556L (de) |
RU (1) | RU2005141060A (de) |
TW (1) | TW200509944A (de) |
UY (1) | UY28400A1 (de) |
WO (1) | WO2005002586A1 (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030216376A1 (en) * | 2002-03-20 | 2003-11-20 | Revital Lifshitz-Liron | Crystalline forms of quetiapine hemifumarate |
WO2008021463A2 (en) * | 2006-08-15 | 2008-02-21 | Acadia Pharmaceuticals, Inc. | Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders |
US20060081361A1 (en) * | 2004-09-13 | 2006-04-20 | Gabbey Lawrence W | Oil cooler with integral filter |
JP2008526839A (ja) * | 2005-01-07 | 2008-07-24 | アストラゼネカ・アクチエボラーグ | 11−ピペラジン−1−イルジベンゾ[b,f][1,4]チアゼピン又はその薬学的に許容される塩の新規な使用及び経口医薬組成物への新規な使用 |
WO2006107948A2 (en) * | 2005-04-04 | 2006-10-12 | Acadia Pharmaceuticals Inc. | Use of n-desmethylclozapine and related compounds as dopamine stabilizing agents |
EP1869007A1 (de) * | 2005-04-14 | 2007-12-26 | Teva Pharmaceutical Industries Ltd | Verfahren zur herstellung von quetiapinfumaraten |
WO2007004234A1 (en) * | 2005-07-04 | 2007-01-11 | Usv Limited | A PROCESS FOR THE PREPARATION OF 2-[2-(4-DIBENZO[b,f] [L,4] THIAZEPIN-11-yl-1- PIPERAZINYL)ETHOXY] ETHANOL FUMARATE |
WO2008079839A1 (en) * | 2006-12-20 | 2008-07-03 | Astrazeneca Ab | Compounds and uses thereof |
WO2007062339A2 (en) * | 2005-11-18 | 2007-05-31 | Astrazeneca Ab | Liquid formulations |
CN101360724A (zh) * | 2005-11-18 | 2009-02-04 | 阿斯利康公司 | 盐形式 |
US8389510B2 (en) | 2005-11-18 | 2013-03-05 | Astrazeneca Ab | Crystalline forms |
WO2007062338A2 (en) * | 2005-11-18 | 2007-05-31 | Astrazeneca Ab | Solid formulations |
WO2007062337A2 (en) * | 2005-11-18 | 2007-05-31 | Astrazeneca Ab | Crystalline forms |
WO2008118141A2 (en) * | 2006-10-17 | 2008-10-02 | Acadia Pharmaceuticals Inc. | Use of cannabinoid modulating compounds in combination with other therapeutic compounds for adjunctive therapy |
JP2010514682A (ja) * | 2006-12-20 | 2010-05-06 | アストラゼネカ・アクチエボラーグ | 化合物及びその使用 |
US20100056492A1 (en) * | 2006-12-20 | 2010-03-04 | Astrazeneca Ab | Compounds and uses thereof - 152 |
JP2010522211A (ja) * | 2007-03-22 | 2010-07-01 | アストラゼネカ・アクチエボラーグ | 気分障害を治療する方法 |
CN102781236B (zh) * | 2009-12-31 | 2015-01-07 | 凯姆制药公司 | 喹硫平的氨基酸缀合物、其制备和使用方法 |
EP2544536B1 (de) | 2010-03-11 | 2018-12-12 | Kempharm, Inc. | Fettsäurekonjugate aus quetiapin sowie verfahren zu ihrer herstellung und verwendung |
CN102552128B (zh) * | 2012-02-28 | 2013-09-18 | 陆荣政 | 一种富马酸喹硫平注射液及其制备方法 |
US9993486B1 (en) | 2017-06-19 | 2018-06-12 | Tlc Therapeutics, Llc | Oral quetiapine suspension formulations with extended shelf life and enhanced bioavailability |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL140242B (nl) * | 1963-03-01 | 1973-11-15 | Wander Ag Dr A | Werkwijze voor het bereiden van op de 11-plaats door een basische groep gesubstitueerde dibenz (b.f.)(1.4) oxazepinen. |
GB1192812A (en) * | 1966-05-20 | 1970-05-20 | American Cyanamid Co | 2-Chloro-11-(1-Piperazinyl)Dibenz[b,f]-[1,4]Oxazepine, Non-Toxic Acid Addition Salts thereof, and Therapeutic Compositions containing said Oxazepine or Salts |
US3539573A (en) * | 1967-03-22 | 1970-11-10 | Jean Schmutz | 11-basic substituted dibenzodiazepines and dibenzothiazepines |
US3966949A (en) * | 1973-10-12 | 1976-06-29 | Richardson-Merrell Inc. | Pharmaceutical compositions and preparing same |
GB8607684D0 (en) * | 1986-03-27 | 1986-04-30 | Ici America Inc | Thiazepine compounds |
US5750566A (en) * | 1994-08-12 | 1998-05-12 | Eli Lilly And Company | Synthetic excitatory amino acids |
US6342488B1 (en) * | 1998-08-18 | 2002-01-29 | Sepracor, Inc. | Phosphonorisperidone and sulforisperidone compositions and methods |
BRPI0406592A (pt) * | 2003-01-23 | 2005-12-20 | Acadia Pharm Inc | Usos de n-desmetilclozapina, métodos para o tratamento de psicose, de distúrbios afetivos, de demência, de dor neuropática e de glaucoma e composição farmacêutica |
-
2004
- 2004-06-28 EP EP04743131A patent/EP1644005B1/de not_active Expired - Lifetime
- 2004-06-28 BR BRPI0412127-9A patent/BRPI0412127A/pt not_active IP Right Cessation
- 2004-06-28 JP JP2006518324A patent/JP2007516193A/ja not_active Ceased
- 2004-06-28 AT AT04743131T patent/ATE477803T1/de not_active IP Right Cessation
- 2004-06-28 CA CA002531284A patent/CA2531284A1/en not_active Abandoned
- 2004-06-28 RU RU2005141060/15A patent/RU2005141060A/ru not_active Application Discontinuation
- 2004-06-28 ES ES04743131T patent/ES2349091T3/es not_active Expired - Lifetime
- 2004-06-28 DE DE602004028739T patent/DE602004028739D1/de not_active Expired - Lifetime
- 2004-06-28 CN CN2004800188710A patent/CN1816339B/zh not_active Expired - Fee Related
- 2004-06-28 AU AU2004253334A patent/AU2004253334A1/en not_active Abandoned
- 2004-06-28 WO PCT/GB2004/002783 patent/WO2005002586A1/en active Search and Examination
- 2004-06-28 MX MXPA05013869A patent/MXPA05013869A/es not_active Application Discontinuation
- 2004-06-28 KR KR1020057025264A patent/KR20060082037A/ko not_active Application Discontinuation
- 2004-07-01 US US10/883,024 patent/US20050026900A1/en not_active Abandoned
- 2004-07-02 UY UY28400A patent/UY28400A1/es not_active Application Discontinuation
- 2004-07-02 AR ARP040102345A patent/AR045004A1/es not_active Application Discontinuation
- 2004-07-02 TW TW093120058A patent/TW200509944A/zh unknown
-
2005
- 2005-12-15 IL IL172616A patent/IL172616A0/en unknown
-
2006
- 2006-02-01 IS IS8283A patent/IS8283A/is unknown
- 2006-02-02 NO NO20060556A patent/NO20060556L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20060556L (no) | 2006-04-03 |
IL172616A0 (en) | 2006-04-10 |
JP2007516193A (ja) | 2007-06-21 |
WO2005002586A8 (en) | 2006-02-09 |
IS8283A (is) | 2006-02-01 |
MXPA05013869A (es) | 2006-02-28 |
TW200509944A (en) | 2005-03-16 |
US20050026900A1 (en) | 2005-02-03 |
AU2004253334A1 (en) | 2005-01-13 |
AR045004A1 (es) | 2005-10-12 |
DE602004028739D1 (de) | 2010-09-30 |
CN1816339A (zh) | 2006-08-09 |
WO2005002586A1 (en) | 2005-01-13 |
RU2005141060A (ru) | 2006-07-27 |
BRPI0412127A (pt) | 2006-08-15 |
KR20060082037A (ko) | 2006-07-14 |
EP1644005B1 (de) | 2010-08-18 |
EP1644005A1 (de) | 2006-04-12 |
UY28400A1 (es) | 2005-01-31 |
CN1816339B (zh) | 2010-12-15 |
ES2349091T3 (es) | 2010-12-27 |
CA2531284A1 (en) | 2005-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE477803T1 (de) | Metabolit von quetiapine | |
DE60309013D1 (de) | Knoten | |
DE60321740D1 (de) | Toner | |
DE60306080D1 (de) | Toner | |
NO20043696L (no) | Gamma-sekretaseinhibitorer | |
ITMI20041123A1 (it) | Fissaggio | |
DK1472255T3 (da) | Aza-arylpiperaziner | |
DE60321615D1 (de) | Toner | |
ATE499348T1 (de) | Stabiler polymorph von bifeprunoxmesilat | |
DE602004024640D1 (de) | Reinigung von titantetrachlorid | |
ITMI20021327A1 (it) | Nuove ossialchilpiperazine | |
ATE410417T1 (de) | Kristallmodifikationen von triazinylaminostilbenen | |
ITMS20020001A1 (it) | Help your self | |
ITMS20020001U1 (it) | Help your self | |
UA8496S (uk) | Комплект етикеток | |
UA7418S (uk) | Комплект етикеток | |
UA9239S (uk) | Комплект етикеток | |
UA9242S (uk) | Комплект етикеток | |
UA9821S (uk) | Комплект етикеток | |
UA8270S (uk) | Комплект етикеток | |
UA8155S (uk) | Комплект етикеток | |
UA7807S (uk) | Комплект етикеток | |
UA8904S (uk) | Комплект етикеток | |
UA6746S (uk) | Кобза чотириструнна | |
FIU20020171U0 (fi) | Puupalkki |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |